TScan Therapeutics Inc (TCRX)

[FACT-MASTER]

I lean to the theory that the TCR-T technology ( although much more research is needed) is a better approach to engaging those intrinsic factors of cancer cells where other therapies such as CAR-T , chemo, etc have only limited capabilities. With the abilities of TargetScan, ReceptorScan and T-Integrate, TCRX may have an ability to deliver the best TCR's, and hopefully with duration.

This should be an interesting trial.

I see your point here:

Personally, I hope TCRX test in a similar patient population. Based on the additional transgenes, should lead to an improved depth and duration of response (assuming dose levels in the same range).

Thank you for the added information.